Title: Nebulized Exosome Therapy for Neurological Disorders: A First-in-Field Case Series
Author: Dr. Dina SOLIMAN
DOI: https://dx.doi.org/10.18535/jmscr/v14i01.03
Abstract
This is, to our knowledge, the first-in-field case series describing the use of nebulized exosomes for different neurological disorders. Chronic neurological disorders often present overlapping mechanisms of neuro-inflammation, oxidative stress, and impaired cellular repair, and are frequently resistant to standard therapies, highlighting the need for innovative, regenerative treatment strategies. Nebulized exosome therapy is an emerging approach for treating neurological and neuro-degenerative disorders. Exosomes are nano-sized vesicles that facilitate intercellular communication and carry bioactive molecules, including neurotrophic factors that may aid in recovery from neurological disorders by promoting regeneration of brain cells and tissue. Objective: To evaluate the clinical effects of nebulized Umbilical Cord-Mesenchymal Stem Cells (UC-MSCs) derived exosomes in treatment of neurological disorders.
Methods: This case series included eight patients, each diagnosed with a single distinct neurological condition: Parkinson’s disease / fibromyalgia / post-stroke / chronic dizziness / dementia / Friedreich’s ataxia / post-covid / repeated extra-dural haemorrhage. All Patients were treated with nebulized UC-MSCs derived exosomes, number of treatments ranged from 1 to 3 treatments per patient, and the interval between treatments was 4 weeks. Patients’ reports were obtained, and subjective clinical assessment and examination were performed for each patient before the treatment, two weeks after each treatment, then six months after the first treatment.
Results: Following nebulized exosome therapy, all patients reported and demonstrated clinical improvement in both symptoms and neurological signs, except for the patient with pre-existing dementia.
Conclusion: UC-MSCs derived exosomes are emerging as a promising tool in regenerative medicine, and they represent a promising frontier in treatment of neuro-degenerative diseases with a significant potential promising therapeutic effect in different neurological disorders.
Keywords: Exosomes, extracellular vesicles, extra-cellular cargo, neuro-inflammatory diseases, intercellular communication, drug delivery, biomarkers, cancer, neuro-degenerative diseases, biogenesis, post-stroke, fibromyalgia, parkinson’s disease, dizziness, extra-dural haemorrhage, dementia, Friedreich’s ataxia, post-covid, neurological disorders.
References
- Alvarez-Erviti, L., et al. (2011). "Exosome-mediated delivery of siRNA in vitro and in vivo." Nature Biotechnology, 29(4), 341-345.
- Cheng, L., et al. (2014). "Exosomes as novel biomarkers for clinical diagnosis." Journal of Molecular Medicine, 92, 1231-1236.
- Feng, Y., et al. (2018). "Exosomes in the treatment of brain diseases." Journal of Controlled Release, 274, 211-222.
- Johnstone, R. M., et al. (1987). "Transfer of membrane proteins to exosomes." Journal of Cell Biology, 105(4), 1343-1351.
- Lai, R. C., et al. (2015). "Exosome therapy for cancer: The state of the art." Exosomes and Microvesicles, 1(1), 27-41.
- Rao, L., & Ghosh, D. (2020). "Exosome-mediated intercellular communication." Cell Communication and Signaling, 18(1), 61.Top of FormBottom of Form
- Raposo, G., & Stoorvogel, W. (2013). "Extracellular vesicles: Exosomes, micro-vesicles, and friends." Journal of Cell Biology, 200(4), 373-383.
- Teng, Y. D., et al. (2015). "Exosome-mediated delivery of RNA across the blood-brain barrier." Advanced Drug Delivery Reviews, 87, 59-71.
- Théry, C., et al. (2002). "Exosomes: Composition, biogenesis, and function." Nature Reviews Immunology, 2(8), 569-579.
- Valadi, H., et al. (2007). "Exosome-mediated transfer of RNAs is a novel mechanism of genetic exchange between cells." Nature Cell Biology, 9(6), 654-659.
- Wang, L., et al. (2017). "MSCs derived exosomes enhance skin wound healing." Cell Transplantation, 26(5), 699-711.
- Xin, H., et al. (2013). "MSCs derived exosomes for tissue repair and regeneration." Exosomes and Microvesicles, 1(2), 103-107.
- Zhang, Y., et al. (2015). "Exosomes derived from MSCs promote angiogenesis in rat." Journal of Cerebral Blood Flow & Metabolism, 35(4), 612-619.
- Zhao, Z., et al. (2016). "Exosomes derived from human MSCs regulate macrophage polarization." Stem Cells International, 2016, Article ID 9649727
